Bartholin gland neoplasm
diseaseOn this page
Also known as Bartholin's gland neoplasmBartholin's gland tumorBartholin's gland tumourmajor vestibular gland neoplasmmajor vestibular gland neoplasm (disease)major vestibular gland tumormajor vestibular gland tumourneoplasm of Bartholin's glandneoplasm of major vestibular glandneoplasm of the Bartholin's glandtumor of Bartholin's glandtumor of major vestibular glandtumor of the Bartholin's glandtumour of Bartholin's glandtumour of major vestibular glandtumour of the Bartholin's gland
Summary
Bartholin gland neoplasm (MONDO:0021114) is a cancer. A subtype of integumentary system disorder — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Classification: Cancer
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | Bartholin gland neoplasm |
| Mondo ID | MONDO:0021114 |
| NCIT | C6434 |
| UMLS | C0220616 |
| MedGen | 65074 |
| Anatomy (UBERON) | UBERON:0000460 |
| Is cancer (heuristic) | yes |
Also known as: Bartholin gland neoplasm · Bartholin’s gland neoplasm · Bartholin’s gland tumor · Bartholin’s gland tumour · major vestibular gland neoplasm · major vestibular gland neoplasm (disease) · major vestibular gland tumor · major vestibular gland tumour · neoplasm of Bartholin’s gland · neoplasm of major vestibular gland · neoplasm of the Bartholin’s gland · tumor of Bartholin’s gland · tumor of major vestibular gland · tumor of the Bartholin’s gland · tumour of Bartholin’s gland · tumour of major vestibular gland · tumour of the Bartholin’s gland
Disease family
An umbrella term covering 2 Mondo subtypes.
Classification path: disease › human disease › disease by body system or component › integumentary system disorder › Bartholin gland neoplasm
Related subtypes (35): Neu-Laxova syndrome, cutaneous mycosis, integumentary system benign neoplasm, integumentary system cancer, nipple neoplasm, nail disorder, disorder of pilosebaceous unit, Bartholin duct cyst, benign mammary dysplasia, skin disorder, breast fibrosis, breast mucosa-associated lymphoid tissue lymphoma, panniculitis, alopecia-epilepsy-pyorrhea-intellectual disability syndrome, autosomal dominant deafness - onychodystrophy syndrome, keratoderma hereditarium mutilans, Rombo syndrome, Sjogren-Larsson syndrome, mucosulfatidosis, ichthyosis prematurity syndrome, ANE syndrome, frontonasal dysplasia with alopecia and genital anomaly, peeling skin-leukonuchia-acral punctate keratoses-cheilitis-knuckle pads syndrome, mandibulofacial dysostosis with alopecia, cutis laxa, X-linked ichthyosis syndrome, demodicidosis, Proteus-like syndrome, familial atypical multiple mole melanoma syndrome, familial tumoral calcinosis, subcutaneous tissue disorder, pseudoxanthoma elasticum (inherited or acquired), skin appendage disorder, keratinization disease, paraneoplastic cutaneous syndrome
Subtypes (2): Bartholin gland benign neoplasm, bartholin gland carcinoma
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 0.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.